nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiotepa—CYP2B6—Nicotine Metabolism—CYP2A6—esophageal cancer	0.0101	0.0678	CbGpPWpGaD
Thiotepa—Leukoderma—Methotrexate—esophageal cancer	0.00683	0.00804	CcSEcCtD
Thiotepa—Cognitive disorder—Methotrexate—esophageal cancer	0.00671	0.0079	CcSEcCtD
Thiotepa—Skin hyperpigmentation—Capecitabine—esophageal cancer	0.00656	0.00772	CcSEcCtD
Thiotepa—Febrile neutropenia—Capecitabine—esophageal cancer	0.00648	0.00763	CcSEcCtD
Thiotepa—Infection—Carboplatin—esophageal cancer	0.0064	0.00753	CcSEcCtD
Thiotepa—CYP2B6—CYP2E1 reactions—CYP2A6—esophageal cancer	0.0062	0.0417	CbGpPWpGaD
Thiotepa—Encephalopathy—Capecitabine—esophageal cancer	0.00608	0.00715	CcSEcCtD
Thiotepa—Hypothyroidism—Capecitabine—esophageal cancer	0.00608	0.00715	CcSEcCtD
Thiotepa—Embolism—Capecitabine—esophageal cancer	0.00608	0.00715	CcSEcCtD
Thiotepa—Extravasation—Cisplatin—esophageal cancer	0.00607	0.00714	CcSEcCtD
Thiotepa—Intestinal obstruction—Capecitabine—esophageal cancer	0.00572	0.00673	CcSEcCtD
Thiotepa—Hyperuricaemia—Cisplatin—esophageal cancer	0.00571	0.00671	CcSEcCtD
Thiotepa—Hearing impaired—Cisplatin—esophageal cancer	0.00556	0.00654	CcSEcCtD
Thiotepa—Hepatomegaly—Capecitabine—esophageal cancer	0.00551	0.00649	CcSEcCtD
Thiotepa—Ileus—Capecitabine—esophageal cancer	0.00551	0.00649	CcSEcCtD
Thiotepa—Pain—Carboplatin—esophageal cancer	0.0055	0.00648	CcSEcCtD
Thiotepa—Blood uric acid increased—Cisplatin—esophageal cancer	0.00539	0.00634	CcSEcCtD
Thiotepa—Vaginal haemorrhage—Capecitabine—esophageal cancer	0.00527	0.0062	CcSEcCtD
Thiotepa—Mucosal inflammation—Methotrexate—esophageal cancer	0.00525	0.00617	CcSEcCtD
Thiotepa—Body temperature increased—Carboplatin—esophageal cancer	0.00509	0.00599	CcSEcCtD
Thiotepa—Skin exfoliation—Cisplatin—esophageal cancer	0.00505	0.00595	CcSEcCtD
Thiotepa—Fluid retention—Cisplatin—esophageal cancer	0.00502	0.00591	CcSEcCtD
Thiotepa—Memory impairment—Capecitabine—esophageal cancer	0.00497	0.00585	CcSEcCtD
Thiotepa—Skin hyperpigmentation—Methotrexate—esophageal cancer	0.00488	0.00575	CcSEcCtD
Thiotepa—Febrile neutropenia—Methotrexate—esophageal cancer	0.00483	0.00568	CcSEcCtD
Thiotepa—Injection site pain—Capecitabine—esophageal cancer	0.00478	0.00562	CcSEcCtD
Thiotepa—Polyp—Methotrexate—esophageal cancer	0.00477	0.00562	CcSEcCtD
Thiotepa—Hypoxia—Methotrexate—esophageal cancer	0.00457	0.00538	CcSEcCtD
Thiotepa—CYP3A4—Codeine and Morphine Metabolism—ABCC2—esophageal cancer	0.00455	0.0306	CbGpPWpGaD
Thiotepa—Embolism—Methotrexate—esophageal cancer	0.00452	0.00532	CcSEcCtD
Thiotepa—Encephalopathy—Methotrexate—esophageal cancer	0.00452	0.00532	CcSEcCtD
Thiotepa—Cyst—Methotrexate—esophageal cancer	0.00434	0.00511	CcSEcCtD
Thiotepa—Skin discolouration—Capecitabine—esophageal cancer	0.00432	0.00508	CcSEcCtD
Thiotepa—Deafness—Cisplatin—esophageal cancer	0.00429	0.00505	CcSEcCtD
Thiotepa—Hyperbilirubinaemia—Capecitabine—esophageal cancer	0.00429	0.00505	CcSEcCtD
Thiotepa—Blood bilirubin increased—Capecitabine—esophageal cancer	0.00412	0.00485	CcSEcCtD
Thiotepa—Cataract—Capecitabine—esophageal cancer	0.0041	0.00482	CcSEcCtD
Thiotepa—Hearing impaired—Capecitabine—esophageal cancer	0.0041	0.00482	CcSEcCtD
Thiotepa—CYP2B6—Xenobiotics—CYP2A6—esophageal cancer	0.00384	0.0259	CbGpPWpGaD
Thiotepa—Colitis—Capecitabine—esophageal cancer	0.00375	0.00441	CcSEcCtD
Thiotepa—Skin exfoliation—Capecitabine—esophageal cancer	0.00372	0.00438	CcSEcCtD
Thiotepa—Fluid retention—Capecitabine—esophageal cancer	0.0037	0.00436	CcSEcCtD
Thiotepa—Blood creatinine increased—Cisplatin—esophageal cancer	0.0036	0.00424	CcSEcCtD
Thiotepa—CYP3A4—Fatty Acid Omega Oxidation—ADH7—esophageal cancer	0.0036	0.0242	CbGpPWpGaD
Thiotepa—Dehydration—Cisplatin—esophageal cancer	0.00357	0.0042	CcSEcCtD
Thiotepa—Oesophagitis—Capecitabine—esophageal cancer	0.00356	0.00419	CcSEcCtD
Thiotepa—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—esophageal cancer	0.00353	0.0238	CbGpPWpGaD
Thiotepa—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—esophageal cancer	0.00353	0.0238	CbGpPWpGaD
Thiotepa—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.00346	0.00407	CcSEcCtD
Thiotepa—Sepsis—Capecitabine—esophageal cancer	0.00339	0.00398	CcSEcCtD
Thiotepa—Extravasation—Methotrexate—esophageal cancer	0.00333	0.00392	CcSEcCtD
Thiotepa—CYP2B6—Constitutive Androstane Receptor Pathway—ABCC2—esophageal cancer	0.0033	0.0222	CbGpPWpGaD
Thiotepa—Blood alkaline phosphatase increased—Capecitabine—esophageal cancer	0.00326	0.00383	CcSEcCtD
Thiotepa—Skin discolouration—Methotrexate—esophageal cancer	0.00322	0.00378	CcSEcCtD
Thiotepa—Hyperbilirubinaemia—Methotrexate—esophageal cancer	0.00319	0.00376	CcSEcCtD
Thiotepa—Deafness—Capecitabine—esophageal cancer	0.00317	0.00373	CcSEcCtD
Thiotepa—CYP3A4—Tryptophan metabolism—ALDH3A2—esophageal cancer	0.00316	0.0213	CbGpPWpGaD
Thiotepa—Pancytopenia—Cisplatin—esophageal cancer	0.00315	0.00371	CcSEcCtD
Thiotepa—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—esophageal cancer	0.00315	0.0212	CbGpPWpGaD
Thiotepa—Oliguria—Methotrexate—esophageal cancer	0.00315	0.00371	CcSEcCtD
Thiotepa—Hepatic failure—Capecitabine—esophageal cancer	0.00315	0.00371	CcSEcCtD
Thiotepa—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—esophageal cancer	0.00315	0.0212	CbGpPWpGaD
Thiotepa—Hyperuricaemia—Methotrexate—esophageal cancer	0.00313	0.00368	CcSEcCtD
Thiotepa—Blood uric acid increased—Methotrexate—esophageal cancer	0.00296	0.00348	CcSEcCtD
Thiotepa—Renal failure—Cisplatin—esophageal cancer	0.00291	0.00342	CcSEcCtD
Thiotepa—CYP3A4—Irinotecan Pathway—ABCC2—esophageal cancer	0.00291	0.0196	CbGpPWpGaD
Thiotepa—Cardiac failure—Capecitabine—esophageal cancer	0.0029	0.00341	CcSEcCtD
Thiotepa—Stomatitis—Cisplatin—esophageal cancer	0.00289	0.0034	CcSEcCtD
Thiotepa—Conjunctivitis—Cisplatin—esophageal cancer	0.00288	0.00339	CcSEcCtD
Thiotepa—Cystitis noninfective—Methotrexate—esophageal cancer	0.00284	0.00334	CcSEcCtD
Thiotepa—Cystitis—Methotrexate—esophageal cancer	0.0028	0.0033	CcSEcCtD
Thiotepa—Hepatobiliary disease—Cisplatin—esophageal cancer	0.0028	0.00329	CcSEcCtD
Thiotepa—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—esophageal cancer	0.00279	0.0188	CbGpPWpGaD
Thiotepa—Skin exfoliation—Methotrexate—esophageal cancer	0.00277	0.00326	CcSEcCtD
Thiotepa—Cardiac arrest—Capecitabine—esophageal cancer	0.00269	0.00317	CcSEcCtD
Thiotepa—Urinary retention—Capecitabine—esophageal cancer	0.00269	0.00317	CcSEcCtD
Thiotepa—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—esophageal cancer	0.00267	0.018	CbGpPWpGaD
Thiotepa—Ataxia—Capecitabine—esophageal cancer	0.00266	0.00313	CcSEcCtD
Thiotepa—Blood creatinine increased—Capecitabine—esophageal cancer	0.00265	0.00312	CcSEcCtD
Thiotepa—CYP2B6—Constitutive Androstane Receptor Pathway—CYP2A6—esophageal cancer	0.00264	0.0178	CbGpPWpGaD
Thiotepa—Dehydration—Capecitabine—esophageal cancer	0.00263	0.0031	CcSEcCtD
Thiotepa—Bladder pain—Methotrexate—esophageal cancer	0.00263	0.00309	CcSEcCtD
Thiotepa—Urinary tract disorder—Cisplatin—esophageal cancer	0.00262	0.00309	CcSEcCtD
Thiotepa—Connective tissue disorder—Cisplatin—esophageal cancer	0.00261	0.00307	CcSEcCtD
Thiotepa—Urethral disorder—Cisplatin—esophageal cancer	0.00261	0.00307	CcSEcCtD
Thiotepa—Pulmonary oedema—Methotrexate—esophageal cancer	0.00258	0.00304	CcSEcCtD
Thiotepa—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.00255	0.003	CcSEcCtD
Thiotepa—Sepsis—Methotrexate—esophageal cancer	0.00252	0.00297	CcSEcCtD
Thiotepa—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.0025	0.00294	CcSEcCtD
Thiotepa—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—esophageal cancer	0.00249	0.0167	CbGpPWpGaD
Thiotepa—Eye disorder—Cisplatin—esophageal cancer	0.00248	0.00292	CcSEcCtD
Thiotepa—Tinnitus—Cisplatin—esophageal cancer	0.00248	0.00292	CcSEcCtD
Thiotepa—Cardiac disorder—Cisplatin—esophageal cancer	0.00247	0.0029	CcSEcCtD
Thiotepa—CYP3A4—Codeine and Morphine Metabolism—ABCB1—esophageal cancer	0.00241	0.0162	CbGpPWpGaD
Thiotepa—Immune system disorder—Cisplatin—esophageal cancer	0.0024	0.00282	CcSEcCtD
Thiotepa—Mediastinal disorder—Cisplatin—esophageal cancer	0.0024	0.00282	CcSEcCtD
Thiotepa—Arrhythmia—Cisplatin—esophageal cancer	0.00237	0.00279	CcSEcCtD
Thiotepa—Alopecia—Cisplatin—esophageal cancer	0.00235	0.00276	CcSEcCtD
Thiotepa—Hepatic failure—Methotrexate—esophageal cancer	0.00235	0.00276	CcSEcCtD
Thiotepa—Pancytopenia—Capecitabine—esophageal cancer	0.00232	0.00274	CcSEcCtD
Thiotepa—Malnutrition—Cisplatin—esophageal cancer	0.00231	0.00272	CcSEcCtD
Thiotepa—Erythema—Cisplatin—esophageal cancer	0.00231	0.00272	CcSEcCtD
Thiotepa—Dysuria—Capecitabine—esophageal cancer	0.00229	0.00269	CcSEcCtD
Thiotepa—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.00224	0.0151	CbGpPWpGaD
Thiotepa—CYP2B6—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.00223	0.015	CbGpPWpGaD
Thiotepa—Weight increased—Capecitabine—esophageal cancer	0.00223	0.00262	CcSEcCtD
Thiotepa—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—esophageal cancer	0.00222	0.0149	CbGpPWpGaD
Thiotepa—CYP2B6—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.00221	0.0149	CbGpPWpGaD
Thiotepa—Hyperglycaemia—Capecitabine—esophageal cancer	0.00221	0.0026	CcSEcCtD
Thiotepa—Pneumonia—Capecitabine—esophageal cancer	0.00219	0.00258	CcSEcCtD
Thiotepa—Infestation—Capecitabine—esophageal cancer	0.00218	0.00257	CcSEcCtD
Thiotepa—Infestation NOS—Capecitabine—esophageal cancer	0.00218	0.00257	CcSEcCtD
Thiotepa—Vision blurred—Cisplatin—esophageal cancer	0.00218	0.00257	CcSEcCtD
Thiotepa—Renal failure—Capecitabine—esophageal cancer	0.00215	0.00252	CcSEcCtD
Thiotepa—Anaemia—Cisplatin—esophageal cancer	0.00214	0.00252	CcSEcCtD
Thiotepa—Stomatitis—Capecitabine—esophageal cancer	0.00213	0.0025	CcSEcCtD
Thiotepa—Jaundice—Capecitabine—esophageal cancer	0.00213	0.0025	CcSEcCtD
Thiotepa—Conjunctivitis—Capecitabine—esophageal cancer	0.00212	0.0025	CcSEcCtD
Thiotepa—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—esophageal cancer	0.00209	0.0141	CbGpPWpGaD
Thiotepa—Haematuria—Capecitabine—esophageal cancer	0.00208	0.00245	CcSEcCtD
Thiotepa—Leukopenia—Cisplatin—esophageal cancer	0.00207	0.00244	CcSEcCtD
Thiotepa—Hepatobiliary disease—Capecitabine—esophageal cancer	0.00206	0.00243	CcSEcCtD
Thiotepa—Epistaxis—Capecitabine—esophageal cancer	0.00206	0.00242	CcSEcCtD
Thiotepa—Agranulocytosis—Capecitabine—esophageal cancer	0.00204	0.0024	CcSEcCtD
Thiotepa—Convulsion—Cisplatin—esophageal cancer	0.002	0.00236	CcSEcCtD
Thiotepa—Ataxia—Methotrexate—esophageal cancer	0.00198	0.00233	CcSEcCtD
Thiotepa—Myalgia—Cisplatin—esophageal cancer	0.00197	0.00232	CcSEcCtD
Thiotepa—Haemoglobin—Capecitabine—esophageal cancer	0.00197	0.00232	CcSEcCtD
Thiotepa—Anxiety—Cisplatin—esophageal cancer	0.00196	0.00231	CcSEcCtD
Thiotepa—Haemorrhage—Capecitabine—esophageal cancer	0.00196	0.00231	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00196	0.0023	CcSEcCtD
Thiotepa—CYP2B6—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.00195	0.0131	CbGpPWpGaD
Thiotepa—Urinary tract disorder—Capecitabine—esophageal cancer	0.00193	0.00228	CcSEcCtD
Thiotepa—Connective tissue disorder—Capecitabine—esophageal cancer	0.00193	0.00227	CcSEcCtD
Thiotepa—Urethral disorder—Capecitabine—esophageal cancer	0.00192	0.00226	CcSEcCtD
Thiotepa—Infection—Cisplatin—esophageal cancer	0.00188	0.00221	CcSEcCtD
Thiotepa—Nervous system disorder—Cisplatin—esophageal cancer	0.00185	0.00218	CcSEcCtD
Thiotepa—Thrombocytopenia—Cisplatin—esophageal cancer	0.00185	0.00218	CcSEcCtD
Thiotepa—Tachycardia—Cisplatin—esophageal cancer	0.00184	0.00217	CcSEcCtD
Thiotepa—Skin disorder—Cisplatin—esophageal cancer	0.00183	0.00216	CcSEcCtD
Thiotepa—Eye disorder—Capecitabine—esophageal cancer	0.00183	0.00215	CcSEcCtD
Thiotepa—Tinnitus—Capecitabine—esophageal cancer	0.00183	0.00215	CcSEcCtD
Thiotepa—Cardiac disorder—Capecitabine—esophageal cancer	0.00182	0.00214	CcSEcCtD
Thiotepa—CYP2B6—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.00182	0.0122	CbGpPWpGaD
Thiotepa—Anorexia—Cisplatin—esophageal cancer	0.0018	0.00212	CcSEcCtD
Thiotepa—Angiopathy—Capecitabine—esophageal cancer	0.00178	0.00209	CcSEcCtD
Thiotepa—Immune system disorder—Capecitabine—esophageal cancer	0.00177	0.00208	CcSEcCtD
Thiotepa—Mediastinal disorder—Capecitabine—esophageal cancer	0.00177	0.00208	CcSEcCtD
Thiotepa—Chills—Capecitabine—esophageal cancer	0.00176	0.00207	CcSEcCtD
Thiotepa—CYP2B6—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	0.00175	0.0118	CbGpPWpGaD
Thiotepa—Arrhythmia—Capecitabine—esophageal cancer	0.00175	0.00206	CcSEcCtD
Thiotepa—CYP3A4—Xenobiotics—CYP2A6—esophageal cancer	0.00175	0.0118	CbGpPWpGaD
Thiotepa—Alopecia—Capecitabine—esophageal cancer	0.00173	0.00204	CcSEcCtD
Thiotepa—Pancytopenia—Methotrexate—esophageal cancer	0.00173	0.00204	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00172	0.00202	CcSEcCtD
Thiotepa—Mental disorder—Capecitabine—esophageal cancer	0.00172	0.00202	CcSEcCtD
Thiotepa—Erythema—Capecitabine—esophageal cancer	0.00171	0.00201	CcSEcCtD
Thiotepa—Malnutrition—Capecitabine—esophageal cancer	0.00171	0.00201	CcSEcCtD
Thiotepa—Dysuria—Methotrexate—esophageal cancer	0.0017	0.002	CcSEcCtD
Thiotepa—Paraesthesia—Cisplatin—esophageal cancer	0.0017	0.002	CcSEcCtD
Thiotepa—CYP3A4—Tamoxifen metabolism—CYP2A6—esophageal cancer	0.00168	0.0113	CbGpPWpGaD
Thiotepa—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.00167	0.0112	CbGpPWpGaD
Thiotepa—Back pain—Capecitabine—esophageal cancer	0.00165	0.00194	CcSEcCtD
Thiotepa—Decreased appetite—Cisplatin—esophageal cancer	0.00164	0.00193	CcSEcCtD
Thiotepa—Pneumonia—Methotrexate—esophageal cancer	0.00163	0.00192	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00163	0.00192	CcSEcCtD
Thiotepa—Infestation—Methotrexate—esophageal cancer	0.00162	0.00191	CcSEcCtD
Thiotepa—Infestation NOS—Methotrexate—esophageal cancer	0.00162	0.00191	CcSEcCtD
Thiotepa—Pain—Cisplatin—esophageal cancer	0.00161	0.0019	CcSEcCtD
Thiotepa—CYP2B6—Cisplatin—esophageal cancer	0.00161	1	CbGbCtD
Thiotepa—Vision blurred—Capecitabine—esophageal cancer	0.00161	0.00189	CcSEcCtD
Thiotepa—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—esophageal cancer	0.0016	0.0108	CbGpPWpGaD
Thiotepa—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—esophageal cancer	0.0016	0.0108	CbGpPWpGaD
Thiotepa—Renal failure—Methotrexate—esophageal cancer	0.0016	0.00188	CcSEcCtD
Thiotepa—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.0016	0.0107	CbGpPWpGaD
Thiotepa—Stomatitis—Methotrexate—esophageal cancer	0.00158	0.00186	CcSEcCtD
Thiotepa—Conjunctivitis—Methotrexate—esophageal cancer	0.00158	0.00186	CcSEcCtD
Thiotepa—Anaemia—Capecitabine—esophageal cancer	0.00158	0.00185	CcSEcCtD
Thiotepa—CYP2B6—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.00158	0.0106	CbGpPWpGaD
Thiotepa—Feeling abnormal—Cisplatin—esophageal cancer	0.00156	0.00183	CcSEcCtD
Thiotepa—Haematuria—Methotrexate—esophageal cancer	0.00155	0.00182	CcSEcCtD
Thiotepa—Hepatobiliary disease—Methotrexate—esophageal cancer	0.00154	0.00181	CcSEcCtD
Thiotepa—Epistaxis—Methotrexate—esophageal cancer	0.00153	0.0018	CcSEcCtD
Thiotepa—CYP3A4—Estrogen metabolism—CYP1B1—esophageal cancer	0.00153	0.0103	CbGpPWpGaD
Thiotepa—Leukopenia—Capecitabine—esophageal cancer	0.00153	0.0018	CcSEcCtD
Thiotepa—Agranulocytosis—Methotrexate—esophageal cancer	0.00152	0.00178	CcSEcCtD
Thiotepa—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—esophageal cancer	0.0015	0.0101	CbGpPWpGaD
Thiotepa—Body temperature increased—Cisplatin—esophageal cancer	0.00149	0.00176	CcSEcCtD
Thiotepa—Cough—Capecitabine—esophageal cancer	0.00149	0.00175	CcSEcCtD
Thiotepa—Hypertension—Capecitabine—esophageal cancer	0.00147	0.00173	CcSEcCtD
Thiotepa—Haemoglobin—Methotrexate—esophageal cancer	0.00147	0.00172	CcSEcCtD
Thiotepa—Haemorrhage—Methotrexate—esophageal cancer	0.00146	0.00172	CcSEcCtD
Thiotepa—Arthralgia—Capecitabine—esophageal cancer	0.00145	0.00171	CcSEcCtD
Thiotepa—Myalgia—Capecitabine—esophageal cancer	0.00145	0.00171	CcSEcCtD
Thiotepa—Anxiety—Capecitabine—esophageal cancer	0.00145	0.0017	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00144	0.0017	CcSEcCtD
Thiotepa—Urinary tract disorder—Methotrexate—esophageal cancer	0.00144	0.00169	CcSEcCtD
Thiotepa—Urethral disorder—Methotrexate—esophageal cancer	0.00143	0.00168	CcSEcCtD
Thiotepa—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—esophageal cancer	0.00143	0.00962	CbGpPWpGaD
Thiotepa—Confusional state—Capecitabine—esophageal cancer	0.0014	0.00165	CcSEcCtD
Thiotepa—Hypersensitivity—Cisplatin—esophageal cancer	0.00139	0.00164	CcSEcCtD
Thiotepa—Infection—Capecitabine—esophageal cancer	0.00138	0.00163	CcSEcCtD
Thiotepa—CYP2B6—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.00138	0.00926	CbGpPWpGaD
Thiotepa—Nervous system disorder—Capecitabine—esophageal cancer	0.00136	0.00161	CcSEcCtD
Thiotepa—Eye disorder—Methotrexate—esophageal cancer	0.00136	0.0016	CcSEcCtD
Thiotepa—Thrombocytopenia—Capecitabine—esophageal cancer	0.00136	0.0016	CcSEcCtD
Thiotepa—Tinnitus—Methotrexate—esophageal cancer	0.00136	0.0016	CcSEcCtD
Thiotepa—Tachycardia—Capecitabine—esophageal cancer	0.00136	0.0016	CcSEcCtD
Thiotepa—Asthenia—Cisplatin—esophageal cancer	0.00135	0.00159	CcSEcCtD
Thiotepa—CYP3A4—Tamoxifen metabolism—CYP1B1—esophageal cancer	0.00135	0.00911	CbGpPWpGaD
Thiotepa—Cardiac disorder—Methotrexate—esophageal cancer	0.00135	0.00159	CcSEcCtD
Thiotepa—Skin disorder—Capecitabine—esophageal cancer	0.00135	0.00159	CcSEcCtD
Thiotepa—Anorexia—Capecitabine—esophageal cancer	0.00133	0.00156	CcSEcCtD
Thiotepa—Angiopathy—Methotrexate—esophageal cancer	0.00132	0.00156	CcSEcCtD
Thiotepa—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—esophageal cancer	0.00132	0.00889	CbGpPWpGaD
Thiotepa—Immune system disorder—Methotrexate—esophageal cancer	0.00132	0.00155	CcSEcCtD
Thiotepa—Mediastinal disorder—Methotrexate—esophageal cancer	0.00131	0.00155	CcSEcCtD
Thiotepa—Chills—Methotrexate—esophageal cancer	0.00131	0.00154	CcSEcCtD
Thiotepa—CYP2B6—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.00129	0.00871	CbGpPWpGaD
Thiotepa—Diarrhoea—Cisplatin—esophageal cancer	0.00129	0.00152	CcSEcCtD
Thiotepa—Alopecia—Methotrexate—esophageal cancer	0.00129	0.00152	CcSEcCtD
Thiotepa—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.00129	0.00866	CbGpPWpGaD
Thiotepa—Mental disorder—Methotrexate—esophageal cancer	0.00128	0.0015	CcSEcCtD
Thiotepa—CYP2B6—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.00127	0.00855	CbGpPWpGaD
Thiotepa—Erythema—Methotrexate—esophageal cancer	0.00127	0.00149	CcSEcCtD
Thiotepa—Malnutrition—Methotrexate—esophageal cancer	0.00127	0.00149	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00127	0.00149	CcSEcCtD
Thiotepa—Paraesthesia—Capecitabine—esophageal cancer	0.00125	0.00147	CcSEcCtD
Thiotepa—Back pain—Methotrexate—esophageal cancer	0.00123	0.00145	CcSEcCtD
Thiotepa—CYP2B6—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.00123	0.00826	CbGpPWpGaD
Thiotepa—Dyspepsia—Capecitabine—esophageal cancer	0.00123	0.00144	CcSEcCtD
Thiotepa—Decreased appetite—Capecitabine—esophageal cancer	0.00121	0.00142	CcSEcCtD
Thiotepa—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.00121	0.00814	CbGpPWpGaD
Thiotepa—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.0012	0.00141	CcSEcCtD
Thiotepa—Vomiting—Cisplatin—esophageal cancer	0.0012	0.00141	CcSEcCtD
Thiotepa—Fatigue—Capecitabine—esophageal cancer	0.0012	0.00141	CcSEcCtD
Thiotepa—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—esophageal cancer	0.0012	0.00807	CbGpPWpGaD
Thiotepa—Vision blurred—Methotrexate—esophageal cancer	0.0012	0.00141	CcSEcCtD
Thiotepa—CYP2B6—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.00119	0.00804	CbGpPWpGaD
Thiotepa—Rash—Cisplatin—esophageal cancer	0.00119	0.0014	CcSEcCtD
Thiotepa—Constipation—Capecitabine—esophageal cancer	0.00119	0.0014	CcSEcCtD
Thiotepa—Pain—Capecitabine—esophageal cancer	0.00119	0.0014	CcSEcCtD
Thiotepa—Dermatitis—Cisplatin—esophageal cancer	0.00119	0.0014	CcSEcCtD
Thiotepa—CYP2B6—Biological oxidations—ADH7—esophageal cancer	0.00118	0.00796	CbGpPWpGaD
Thiotepa—Anaemia—Methotrexate—esophageal cancer	0.00117	0.00138	CcSEcCtD
Thiotepa—Feeling abnormal—Capecitabine—esophageal cancer	0.00115	0.00135	CcSEcCtD
Thiotepa—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00114	0.00134	CcSEcCtD
Thiotepa—Leukopenia—Methotrexate—esophageal cancer	0.00114	0.00134	CcSEcCtD
Thiotepa—Nausea—Cisplatin—esophageal cancer	0.00112	0.00132	CcSEcCtD
Thiotepa—Cough—Methotrexate—esophageal cancer	0.00111	0.0013	CcSEcCtD
Thiotepa—Urticaria—Capecitabine—esophageal cancer	0.00111	0.0013	CcSEcCtD
Thiotepa—Abdominal pain—Capecitabine—esophageal cancer	0.0011	0.00129	CcSEcCtD
Thiotepa—Body temperature increased—Capecitabine—esophageal cancer	0.0011	0.00129	CcSEcCtD
Thiotepa—Convulsion—Methotrexate—esophageal cancer	0.0011	0.00129	CcSEcCtD
Thiotepa—Arthralgia—Methotrexate—esophageal cancer	0.00108	0.00127	CcSEcCtD
Thiotepa—Myalgia—Methotrexate—esophageal cancer	0.00108	0.00127	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00107	0.00126	CcSEcCtD
Thiotepa—Confusional state—Methotrexate—esophageal cancer	0.00104	0.00123	CcSEcCtD
Thiotepa—CYP2B6—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.00104	0.00702	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—ADH1B—esophageal cancer	0.00104	0.00698	CbGpPWpGaD
Thiotepa—Infection—Methotrexate—esophageal cancer	0.00103	0.00121	CcSEcCtD
Thiotepa—Hypersensitivity—Capecitabine—esophageal cancer	0.00103	0.00121	CcSEcCtD
Thiotepa—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.00102	0.00685	CbGpPWpGaD
Thiotepa—Nervous system disorder—Methotrexate—esophageal cancer	0.00102	0.0012	CcSEcCtD
Thiotepa—Thrombocytopenia—Methotrexate—esophageal cancer	0.00101	0.00119	CcSEcCtD
Thiotepa—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.00101	0.00681	CbGpPWpGaD
Thiotepa—Skin disorder—Methotrexate—esophageal cancer	0.00101	0.00118	CcSEcCtD
Thiotepa—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.001	0.00676	CbGpPWpGaD
Thiotepa—Asthenia—Capecitabine—esophageal cancer	0.000999	0.00118	CcSEcCtD
Thiotepa—Anorexia—Methotrexate—esophageal cancer	0.000988	0.00116	CcSEcCtD
Thiotepa—Pruritus—Capecitabine—esophageal cancer	0.000985	0.00116	CcSEcCtD
Thiotepa—CYP2B6—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000981	0.0066	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—CYP26A1—esophageal cancer	0.000965	0.00649	CbGpPWpGaD
Thiotepa—CYP3A4—Tryptophan metabolism—ALDH2—esophageal cancer	0.000954	0.00642	CbGpPWpGaD
Thiotepa—Diarrhoea—Capecitabine—esophageal cancer	0.000952	0.00112	CcSEcCtD
Thiotepa—CYP2B6—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000952	0.0064	CbGpPWpGaD
Thiotepa—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000944	0.00111	CcSEcCtD
Thiotepa—Paraesthesia—Methotrexate—esophageal cancer	0.00093	0.00109	CcSEcCtD
Thiotepa—Somnolence—Methotrexate—esophageal cancer	0.000921	0.00108	CcSEcCtD
Thiotepa—Dizziness—Capecitabine—esophageal cancer	0.00092	0.00108	CcSEcCtD
Thiotepa—Dyspepsia—Methotrexate—esophageal cancer	0.000912	0.00107	CcSEcCtD
Thiotepa—Decreased appetite—Methotrexate—esophageal cancer	0.000901	0.00106	CcSEcCtD
Thiotepa—CYP2B6—Biological oxidations—GSTO1—esophageal cancer	0.000897	0.00604	CbGpPWpGaD
Thiotepa—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000895	0.00105	CcSEcCtD
Thiotepa—Fatigue—Methotrexate—esophageal cancer	0.000893	0.00105	CcSEcCtD
Thiotepa—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.000888	0.00597	CbGpPWpGaD
Thiotepa—Pain—Methotrexate—esophageal cancer	0.000886	0.00104	CcSEcCtD
Thiotepa—Vomiting—Capecitabine—esophageal cancer	0.000885	0.00104	CcSEcCtD
Thiotepa—CYP2B6—Metapathway biotransformation—GSTO1—esophageal cancer	0.000885	0.00595	CbGpPWpGaD
Thiotepa—Rash—Capecitabine—esophageal cancer	0.000878	0.00103	CcSEcCtD
Thiotepa—Dermatitis—Capecitabine—esophageal cancer	0.000877	0.00103	CcSEcCtD
Thiotepa—Headache—Capecitabine—esophageal cancer	0.000872	0.00103	CcSEcCtD
Thiotepa—Feeling abnormal—Methotrexate—esophageal cancer	0.000854	0.001	CcSEcCtD
Thiotepa—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000847	0.000997	CcSEcCtD
Thiotepa—Nausea—Capecitabine—esophageal cancer	0.000827	0.000973	CcSEcCtD
Thiotepa—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.000825	0.00555	CbGpPWpGaD
Thiotepa—Urticaria—Methotrexate—esophageal cancer	0.000823	0.000969	CcSEcCtD
Thiotepa—Abdominal pain—Methotrexate—esophageal cancer	0.000819	0.000964	CcSEcCtD
Thiotepa—Body temperature increased—Methotrexate—esophageal cancer	0.000819	0.000964	CcSEcCtD
Thiotepa—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	0.000796	0.00536	CbGpPWpGaD
Thiotepa—Hypersensitivity—Methotrexate—esophageal cancer	0.000763	0.000898	CcSEcCtD
Thiotepa—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.000759	0.0051	CbGpPWpGaD
Thiotepa—Asthenia—Methotrexate—esophageal cancer	0.000743	0.000875	CcSEcCtD
Thiotepa—Pruritus—Methotrexate—esophageal cancer	0.000733	0.000863	CcSEcCtD
Thiotepa—CYP2B6—Biological oxidations—ALDH2—esophageal cancer	0.000731	0.00492	CbGpPWpGaD
Thiotepa—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.000725	0.00488	CbGpPWpGaD
Thiotepa—CYP3A4—Tryptophan metabolism—CYP1B1—esophageal cancer	0.000723	0.00487	CbGpPWpGaD
Thiotepa—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.000716	0.00482	CbGpPWpGaD
Thiotepa—Diarrhoea—Methotrexate—esophageal cancer	0.000709	0.000834	CcSEcCtD
Thiotepa—CYP2B6—Biological oxidations—GSTT1—esophageal cancer	0.000695	0.00468	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—CYP2A6—esophageal cancer	0.000687	0.00463	CbGpPWpGaD
Thiotepa—Dizziness—Methotrexate—esophageal cancer	0.000685	0.000806	CcSEcCtD
Thiotepa—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	0.00068	0.00458	CbGpPWpGaD
Thiotepa—Vomiting—Methotrexate—esophageal cancer	0.000659	0.000775	CcSEcCtD
Thiotepa—Rash—Methotrexate—esophageal cancer	0.000653	0.000769	CcSEcCtD
Thiotepa—Dermatitis—Methotrexate—esophageal cancer	0.000653	0.000768	CcSEcCtD
Thiotepa—CYP2B6—Biological oxidations—PTGS1—esophageal cancer	0.000652	0.00439	CbGpPWpGaD
Thiotepa—Headache—Methotrexate—esophageal cancer	0.000649	0.000764	CcSEcCtD
Thiotepa—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000626	0.00421	CbGpPWpGaD
Thiotepa—Nausea—Methotrexate—esophageal cancer	0.000615	0.000724	CcSEcCtD
Thiotepa—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000588	0.00396	CbGpPWpGaD
Thiotepa—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000585	0.00394	CbGpPWpGaD
Thiotepa—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000577	0.00388	CbGpPWpGaD
Thiotepa—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000558	0.00375	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—CYP1B1—esophageal cancer	0.000554	0.00373	CbGpPWpGaD
Thiotepa—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.00055	0.0037	CbGpPWpGaD
Thiotepa—CYP2B6—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000547	0.00368	CbGpPWpGaD
Thiotepa—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000543	0.00365	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.000538	0.00362	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—CYP19A1—esophageal cancer	0.000521	0.00351	CbGpPWpGaD
Thiotepa—CYP2B6—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000514	0.00346	CbGpPWpGaD
Thiotepa—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000474	0.00319	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000472	0.00317	CbGpPWpGaD
Thiotepa—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000446	0.003	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000438	0.00295	CbGpPWpGaD
Thiotepa—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000432	0.00291	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.000408	0.00274	CbGpPWpGaD
Thiotepa—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000402	0.00271	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000332	0.00224	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.000316	0.00213	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000312	0.0021	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000296	0.00199	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—SLC52A3—esophageal cancer	0.00028	0.00188	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—BLVRB—esophageal cancer	0.00028	0.00188	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.000252	0.00169	CbGpPWpGaD
Thiotepa—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000248	0.00167	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—SLC10A2—esophageal cancer	0.000238	0.0016	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CA1—esophageal cancer	0.000238	0.0016	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000237	0.00159	CbGpPWpGaD
Thiotepa—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000233	0.00157	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CA2—esophageal cancer	0.000218	0.00147	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ADH7—esophageal cancer	0.000202	0.00136	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PLCE1—esophageal cancer	0.000202	0.00136	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ADH1B—esophageal cancer	0.000177	0.00119	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—TYMP—esophageal cancer	0.00017	0.00114	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CYP26A1—esophageal cancer	0.000165	0.00111	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ALOX15—esophageal cancer	0.000161	0.00108	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GSTO1—esophageal cancer	0.000153	0.00103	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—TPI1—esophageal cancer	0.000153	0.00103	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ALDOB—esophageal cancer	0.000147	0.00099	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GAPDH—esophageal cancer	0.000142	0.000953	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CRABP1—esophageal cancer	0.00014	0.000944	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GNG7—esophageal cancer	0.000133	0.000898	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.000127	0.000856	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.000127	0.000856	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ALDH2—esophageal cancer	0.000125	0.000842	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GSTT1—esophageal cancer	0.000119	0.0008	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CYP2A6—esophageal cancer	0.000118	0.000791	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ENO1—esophageal cancer	0.000111	0.00075	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PTGS1—esophageal cancer	0.000111	0.00075	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PSME1—esophageal cancer	0.00011	0.000739	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PSME2—esophageal cancer	0.00011	0.000739	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—SLC10A2—esophageal cancer	0.000108	0.000728	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CA1—esophageal cancer	0.000108	0.000728	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CA2—esophageal cancer	9.89e-05	0.000666	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CYP1B1—esophageal cancer	9.48e-05	0.000638	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PLCE1—esophageal cancer	9.2e-05	0.000619	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ADH7—esophageal cancer	9.2e-05	0.000619	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CYP19A1—esophageal cancer	8.91e-05	0.0006	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—HMOX1—esophageal cancer	8.13e-05	0.000547	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ADH1B—esophageal cancer	8.06e-05	0.000543	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ABCB1—esophageal cancer	7.8e-05	0.000525	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—TYMP—esophageal cancer	7.71e-05	0.000519	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CYP26A1—esophageal cancer	7.5e-05	0.000505	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ALOX15—esophageal cancer	7.31e-05	0.000492	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GSTO1—esophageal cancer	6.97e-05	0.000469	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—TPI1—esophageal cancer	6.97e-05	0.000469	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ALDOB—esophageal cancer	6.68e-05	0.00045	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GAPDH—esophageal cancer	6.43e-05	0.000433	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CRABP1—esophageal cancer	6.38e-05	0.000429	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GNG7—esophageal cancer	6.06e-05	0.000408	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ALDH2—esophageal cancer	5.68e-05	0.000382	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GSTT1—esophageal cancer	5.4e-05	0.000364	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CYP2A6—esophageal cancer	5.34e-05	0.00036	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CREBBP—esophageal cancer	5.22e-05	0.000351	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PTGS1—esophageal cancer	5.06e-05	0.000341	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ENO1—esophageal cancer	5.06e-05	0.000341	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PSME2—esophageal cancer	4.99e-05	0.000336	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PSME1—esophageal cancer	4.99e-05	0.000336	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—NOS3—esophageal cancer	4.67e-05	0.000314	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CYP1B1—esophageal cancer	4.31e-05	0.00029	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PTGS2—esophageal cancer	4.27e-05	0.000287	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CYP19A1—esophageal cancer	4.05e-05	0.000272	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—HMOX1—esophageal cancer	3.69e-05	0.000249	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—EP300—esophageal cancer	3.55e-05	0.000239	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ABCB1—esophageal cancer	3.55e-05	0.000239	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PIK3CA—esophageal cancer	2.63e-05	0.000177	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CREBBP—esophageal cancer	2.37e-05	0.00016	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—NOS3—esophageal cancer	2.12e-05	0.000143	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.94e-05	0.000131	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—EP300—esophageal cancer	1.61e-05	0.000109	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.19e-05	8.04e-05	CbGpPWpGaD
